Step 15 — Scenario, Stress, and Base-Rate Analysis

Key Findings

Net direction for thesis: Moderately negative. Scenario analysis reveals a wide outcome distribution ($12-45 per share range) with asymmetric near-term downside driven by the lockup unlock and active securities investigations. Base rates for recent similar controlled-company IPOs with governance concerns (Palantir 2020, Snowflake 2020, Coinbase 2021) are mixed — none cleanly comparable. The most appropriate analog is Rivian (2021 IPO): controlled structure, hype-driven IPO, post-IPO disclosure events, stock cratered -70% from peak over 2-3 years as fundamentals were reassessed. EquipmentShare's fundamentals are better than Rivian's were, but the path-of-price pattern is recognizable.

Monte Carlo not used — deterministic scenarios are sufficient given the binary nature of the governance events.

Key Kahneman bias flags identified:

• Anchoring on IPO first-day close ($32.56): Investors anchor on the peak-momentum price; base-rate says most IPOs that pop +30% decline from that peak within 12 months
• Saliency of T3/OWN "platform thesis": Makes the narrative feel more differentiated than the balance sheet suggests
• Planning fallacy on mature-site ramp: Management's 24-month maturation is narratively clean but unverified at scale
• Groupthink (9 analysts at "Buy"): Consensus is stale and likely anchored to pre-March 18 disclosure
• Competitor neglect (URI counter-response): Scenarios must include URI launching competing T3-equivalent platform within 2-3 years

Scenarios

Scenario 1: Bull — "Thesis Validates" (Probability: 25%)

Drivers:

• FY2026 revenue beats mid-guide to $5.40B+ (+23%+ growth)
• FY2026 Adj EBITDA clean beats analyst estimate to $1.75B+
• Chheda case dismissed or settled without material findings
• No short-seller report published
• OWN Program regulatory all-clear
• Mature-site economics confirmed across 8 quarters
• Sell-side analyst target revisions converge around $35-45

Fair value:

• DCF base case: ~$35
• Multiple-based (8x FY2027E clean EBITDA $2.0B): ~$45
• Target: $38-45

Path:

• Q1 2026 solid (~mid-May 2026)
• Q2 2026 solid, lockup unlock absorbed quietly (~July 2026)
• Q3 2026 solid, growth rate stabilizing mid-20s (~Nov 2026)
• FY2026 full-year meets or exceeds guide (Feb 2027)
• Valuation re-rates into FY2027 earnings delivery

Scenario 2: Base — "Mixed Execution" (Probability: 40%)

Drivers:

• FY2026 revenue meets or slightly misses mid-guide
• FY2026 Adj EBITDA misses reported $1.87B mid-guide by 5-10% (clean equivalent $1.60-1.70B)
• Chheda case slowly grinds; settlement or dismissal in 2027-2028
• One short-seller report published mid-2026; stock absorbs over 3 months
• Lockup unlock produces modest selling pressure; stock down 10-15% over July-September 2026
• Multiple stays at 5-6x EV/EBITDA

Fair value:

• DCF base case with moderate governance overhang: ~$28
• Multiple-based at 6x FY2027E clean: ~$32
• Target: $26-32

Path:

• Q1 2026 meets guide within 3% (~mid-May 2026)
• Lockup unlock chops stock 10-15% over July-Sept 2026
• Q3 2026 guidance reiteration but at mid- to low-end of original range
• FY2026 lands at lower end of guide
• FY2027 growth decelerates to +15%; multiple compresses slightly

Scenario 3: Bear — "Thesis Breaks" (Probability: 35%)

Drivers:

• Short-seller report published (probability 65% per Step 11) with new documentation
• Formal securities class action filed (probability 65% per Step 04)
• One or more SEC / FINRA inquiries
• Lockup unlock triggers coordinated VC selling over 30-60 days, -20-30% mechanical move
• Fundamental misses compound: Q2 or Q3 2026 EBITDA misses guide by 10%+
• Sell-side downgrades to "Hold" or "Sell"
• Governance discount widens to 30%+
• Multiple compresses to 4.5-5.5x

Fair value:

• DCF with 30% governance discount + class-action overhang: ~$18
• Multiple-based at 5x FY2027E clean ($1.8B if missed guide): ~$12
• Target: $12-18

Path:

• Stock bleeds to $18 by July (lockup + class-action reactions)
• July 23 unlock + coordinated VC selling drive stock to $14-16 by Sept
• Q3 2026 earnings with cautious tone; stock stays $13-16
• Bottom around $12-15 in late 2026
• Gradual recovery requires Chheda resolution + clean FY2026 close

Severe Downside: "Rivian Scenario" (~10% within Bear)

Stress test: Short-seller report + SEC enforcement + fraud finding on Schlacks-entity transactions. Would require coordinated negative events. Fair value $5-8/share (-65% to -75% from spot). Very low probability but non-zero.

Lockup-Unlock Mechanical Selling (Bear Case Component)

Sized per Step 06 analysis:

• 220M shares unlock 2026-07-23
• Pre-unlock ADTV: ~2-4M shares
• Scenario: 10% of locked shares sold over 30 days = 22M shares
• Absorbing 22M shares requires ~15-25% price discount over 30 days
• This is INDEPENDENT of fundamental news — pure supply/demand

Scenario ranges:

• Mild (10% of locked sold): -8% to -12% in 30 days
• Base (20% sold): -15% to -20% in 30 days
• Severe (40% sold; panic + coordinated VC exit): -25% to -35% in 30 days

Base Rate Analysis

Recent similar IPOs — controlled-company + governance concerns

Base rate observation: Post-IPO peak-to-trough drawdowns of -40% to -75% are the norm for controlled-company IPOs with governance concerns. EquipmentShare is -34% from Day-1 peak as of research date — well within the band but not at the depths of comparable drawdowns.

Kahneman bias checklist

Assumption Register Updates

Tables and Calculations

Table 1 — Scenario summary

Table 2 — Timeline of scenario triggers

Open Questions and Data Gaps

1. What is the actual pre-lockup float behavior — short interest ratio? Borrow cost?
2. Are any VC holders (Insight, BDT) signaling secondary-sale intent?
3. Is there a private secondary market for EQPT shares operating pre-unlock?

Next-Step Dependencies

Step 16 (Variant + Catalysts) should enumerate specific dated catalyst events and convert Step 15 scenarios into observable CAT- / EX- row triggers.

Source Index